Cortexyme's Alzheimer's Drug Fails -- 2 Lessons for Investors

Cortexyme's Alzheimer's Drug Fails -- 2 Lessons for Investors

Another new drug candidate for the treatment of Alzheimer's disease failed miserably in a clinical trial.